PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.84%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
2.67%
Positive gross profit growth while CVE is negative. John Neff would see a clear operational edge over the competitor.
4.38%
Positive EBIT growth while CVE is negative. John Neff might see a substantial edge in operational management.
4.38%
Positive operating income growth while CVE is negative. John Neff might view this as a competitive edge in operations.
-63.06%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-63.64%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-63.20%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-2.03%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.56%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-51.01%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-15.63%
Negative OCF growth while CVE is at 80.53%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-565.57%
Negative FCF growth while CVE is at 1306.98%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-42.08%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-42.08%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-42.08%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33.38%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-33.38%
Negative 5Y net income/share CAGR while CVE is 100.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-33.38%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
75.99%
Positive growth while CVE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
75.99%
Positive 5Y equity/share CAGR while CVE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
75.99%
Positive short-term equity growth while CVE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.31%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
59.61%
We show growth while CVE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.67%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.99%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
13.61%
We have some new debt while CVE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-2.69%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.